sugemalimab
Showing 1 - 3 of 3
Extranodal NK/T-cell Lymphoma Trial (Sugemalimab, Placebo, Pegaspargase)
Not yet recruiting
- Extranodal NK/T-cell Lymphoma
- Sugemalimab
- +4 more
- (no location specified)
Jan 17, 2023
Limited Stage Small Cell Lung Cancer Trial in Guangzhou (Sugemalimab, Placebo)
Not yet recruiting
- Limited Stage Small Cell Lung Cancer
- Sugemalimab
- Placebo
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 12, 2022
Extranodal NK/T-cell Lymphoma Trial in Houston (sugemalimab)
Available
- Extranodal NK/T-cell Lymphoma
- sugemalimab
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 18, 2022